Simplex Trading’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$837K Buy
290,700
+142,500
+96% +$561K ﹤0.01% 2691
2025
Q4
$603K Buy
148,200
+119,300
+413% +$534K ﹤0.01% 3118
2025
Q3
$102K Sell
28,900
-18,700
-39% -$67.6K ﹤0.01% 5731
2025
Q2
$129K Sell
47,600
-78,400
-62% -$162K ﹤0.01% 4979
2025
Q1
$211K Sell
126,000
-171,100
-58% -$478K ﹤0.01% 4267
2024
Q4
$484K Sell
297,100
-400
-0.1% -$1.19K ﹤0.01% 3575
2024
Q3
$1.24M Buy
297,500
+296,000
+19,733% +$1.56M ﹤0.01% 2711
2024
Q2
$8K Sell
1,500
-35,800
-96% -$285K ﹤0.01% 7612
2024
Q1
$373K Buy
+37,300
New +$279K ﹤0.01% 4153
2023
Q4
Sell
-6,600
Closed -$25K 9697
2023
Q3
$25K Sell
6,600
-412,800
-98% -$2.22M ﹤0.01% 6436
2023
Q2
$2.5M Buy
419,400
+417,900
+27,860% +$2.41M ﹤0.01% 1798
2023
Q1
$4K Buy
1,500
+1,000
+200% +$4K ﹤0.01% 8215
2022
Q4
$1K Sell
500
-4,000
-89% -$19.6K ﹤0.01% 8910
2022
Q3
$27K Buy
4,500
+2,100
+88% +$15.2K ﹤0.01% 7196
2022
Q2
$15K Buy
+2,400
New +$15.3K ﹤0.01% 7894
2022
Q1
Sell
-400
Closed -$6K 11267
2021
Q4
$6K Buy
400
+100
+33% +$1.93K ﹤0.01% 9432
2021
Q3
$5K Hold
300
﹤0.01% 9290
2021
Q2
$5K Buy
+300
New +$6.8K ﹤0.01% 9476

Other funds holding SANA

Simplex Trading's SANA Position: Q1 2026 in Review

Simplex Trading sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 5,996 shares — an estimated $23.6K sold.

Simplex Trading first reported a position in SANA in Q2 2021 and held it in 15 quarters. The position peaked at $465K in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Simplex Trading reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 5,996 Sana Biotechnology shares in Q1 2026, an estimated $23.6K.
  • Simplex Trading first reported a position in Sana Biotechnology in Q2 2021 and held it in 15 quarters.
  • Simplex Trading's Sana Biotechnology position peaked at $465K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.